Dr. Lal PathLabs Limited Stock

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. 07:43:53 2024-05-31 am EDT 5-day change 1st Jan Change
2,648 INR +0.78% Intraday chart for Dr. Lal PathLabs Limited +0.82% +2.72%
Sales 2024 22.27B 267M Sales 2025 * 24.98B 299M Capitalization 220B 2.64B
Net income 2024 3.58B 42.88M Net income 2025 * 4.18B 50.07M EV / Sales 2024 8.44 x
Net cash position 2024 * 7.68B 92.08M Net cash position 2025 * 10.03B 120M EV / Sales 2025 * 8.4 x
P/E ratio 2024
52.6 x
P/E ratio 2025 *
53 x
Employees 4,048
Yield 2024 *
0.64%
Yield 2025 *
0.83%
Free-Float 43.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.78%
1 week+0.82%
1 month+11.61%
3 months+12.59%
6 months-1.85%
Current year+2.72%
More quotes
1 week
2 571.60
Extreme 2571.6
2 660.00
1 month
2 201.20
Extreme 2201.2
2 660.00
Current year
1 943.70
Extreme 1943.7
2 662.00
1 year
1 916.05
Extreme 1916.05
2 767.10
3 years
1 762.05
Extreme 1762.05
4 245.50
5 years
1 020.00
Extreme 1020
4 245.50
10 years
696.50
Extreme 696.5
4 245.50
More quotes
Managers TitleAgeSince
Chief Executive Officer - 14-06-30
Director of Finance/CFO - 05-12-31
Chairman 74 95-02-13
Members of the board TitleAgeSince
Director/Board Member 58 23-07-26
Director/Board Member 77 15-08-20
Chairman 74 95-02-13
More insiders
Date Price Change Volume
24-05-31 2,648 +0.78% 215,608
24-05-30 2,627 -1.01% 151,205
24-05-29 2,654 +1.41% 166,094
24-05-28 2,617 -0.58% 105,942
24-05-27 2,632 +0.23% 109,773

Delayed Quote NSE India S.E., May 31, 2024 at 07:43 am EDT

More quotes
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
2,648 INR
Average target price
2,489 INR
Spread / Average Target
-6.00%
Consensus
  1. Stock Market
  2. Equities
  3. LALPATHLAB Stock